SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001206774-21-002798
Filing Date
2021-12-02
Accepted
2021-12-02 07:50:37
Documents
12
Period of Report
2021-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron3989111-8k.htm   iXBRL 8-K 27766
  Complete submission text file 0001206774-21-002798.txt   199383

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gern-20211201.xsd EX-101.SCH 3016
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20211201_pre.xml EX-101.PRE 22353
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20211201_lab.xml EX-101.LAB 34240
5 EXTRACTED XBRL INSTANCE DOCUMENT geron3989111-8k_htm.xml XML 3594
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 211464975
SIC: 2834 Pharmaceutical Preparations